Overview Request Sample Pages Request Customization Download PDF
You are viewing: Europe Point-of-Care Molecular Diagnostics Market analysis

The Europe Point-of-Care Molecular Diagnostics Market was valued at $870.7 Million in 2025 and projected to reach to $1531.3 Million by 2030, representing a compound annual growth rate of 12.0%. Europe's point-of-care molecular diagnostics market is positioned for sustained expansion through 2030, driven by increasing prevalence of infectious diseases, growing demand for rapid testing in primary care settings, and strong regulatory support from European health authorities.

Europe Point-of-Care Molecular Diagnostics Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Europe Point-of-Care Molecular Diagnostics Market Trends and Insights

  • This 12.0% compound annual growth rate significantly outpaces the global average, reflecting Europe's advanced healthcare infrastructure, regulatory support, and strong adoption of rapid diagnostic technologies.
  • Europe's market leadership is driven by increasing demand for decentralized testing, rising prevalence of infectious diseases, and substantial investment in point-of-care innovation across clinical and non-clinical settings. The European market benefits from stringent quality standards, established reimbursement frameworks, and a mature healthcare ecosystem that prioritizes rapid patient outcomes.
  • Between 2025 and 2030, Europe is expected to consolidate its position as a key growth region, supported by aging populations, heightened focus on pandemic preparedness, and integration of molecular diagnostics into primary care and emergency departments.
  • Strategic partnerships, regulatory approvals, and technological advancements in miniaturization and automation will further accelerate market penetration across Western and Eastern European markets..

Key Market Statistics

  • CAGR (2025-2030) 12.0% CAGR
  • Market Size, 2025 ~USD 870.7 Million
  • Forecast, 2030 ~USD 1531.3 Million
  • Geography Europe

Europe Point-of-Care Molecular Diagnostics Market Overview

Market Leadership Position :

Europe commands a significant share of the global point-of-care molecular diagnostics market, with a regional valuation of $870.7 million in 2025, demonstrating strong market maturity and healthcare investment across the continent.

Outpacing Global Growth :

Europe's 12.0% CAGR substantially exceeds the global average of 10.5%, driven by advanced healthcare infrastructure, stringent regulatory frameworks, and widespread adoption of rapid diagnostic technologies in clinical settings.

Germany Leads Regional Markets :

Germany dominates European adoption with a market size of $559 million, followed by the UK at $468 million and France at $209.8 million, reflecting strong healthcare spending and diagnostic innovation across Western Europe.

Forecast Growth Trajectory :

The European market is projected to expand to $1,531.3 million by 2030, representing a 76% increase over five years and underscoring sustained demand for rapid, accurate molecular diagnostic solutions across healthcare systems.

Europe Point-of-Care Molecular Diagnostics Market Dynamics

  • The region's advanced healthcare infrastructure and high diagnostic adoption rates create favorable conditions for market penetration and innovation. Key growth catalysts include integration of molecular diagnostics into routine clinical workflows, expansion of testing capabilities in decentralized settings, and rising healthcare expenditure across EU member states.
  • Strategic investments by leading diagnostics manufacturers and partnerships with healthcare providers are expected to accelerate market development, particularly in emerging European markets beyond the traditional Western European strongholds..

Related Ecosystem

In Vitro Diagnostics

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Dna Microarrays
  • Assay Kits
  • Microarrays
Top Companies
  • ROCHE HOLDINGS AG
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Abbott Laboratories
  • Biomerieux s.a.

    Medical Devices

    Top Technologies
    • Polymerase Chain Reaction (PCR)
    • Magnetic Resonance Imaging (MRI)
    • Disposable Autoinjectors
    • Pulse Oximeters
    • Blood Pressure Monitors
    Top Companies
    • Medtronic plc
    • Abbott Laboratories
    • Stryker Corporation
    • Becton, Dickinson and Company
    • JOHNSON & JOHNSON

      Key Takeaways

      • Europe's point-of-care molecular diagnostics market is valued at $870.7 million in 2025 and projected to grow to $1,531.3 million by 2030, representing a 12.0% CAGR.
      • Europe's growth rate outpaces the global average, driven by advanced healthcare infrastructure, regulatory frameworks, and high adoption of rapid diagnostic technologies.
      • Key growth drivers include aging populations, pandemic preparedness initiatives, and integration of molecular diagnostics into primary care and emergency settings across Europe.
      • Strategic partnerships, regulatory approvals, and technological innovations in miniaturization will accelerate market expansion across Western and Eastern European regions through 2030.

      Point-of-Care Molecular Diagnostics Market Report Scope

      Report Metric Details
      Base Year 2025
      Fastest Growing Segment SEPSIS (Disease Type)
      Forecast Period 2025-2030
      Growth Rate CAGR of 10.5% from 2025 to 2030
      Largest Segment RT-PCR (Technology)
      Market Size Base Year (Billions) ~USD 4.3 (2025)
      Revenue Forecast (Billions) ~USD 7.09 (2030)
      Segments Covered Product & Service, Technology, Sample Type, Application, End User, Disease Type

      Europe Point-of-Care Molecular Diagnostics Market Report Segmentation

      6 segment dimensions are covered across the global market.

      By Product & Service

      • Assays & Kits
      • Instruments & Analyzers
      • Software & Services

      By Technology

      • Inaat
      • Other Technologies
      • Rt-Pcr

      By Sample Type

      • Blood Samples
      • Other Sample Types
      • Urine Samples

      By Application

      • Cancer
      • Gastrointestinal Disorders
      • Hepatitis
      • Hospital-Acquired Infections
      • Other Applications
      • Respiratory Diseases
      • Sexually Transmitted Diseases

      By End User

      • Hospitals
      • Other End Users
      • Physicians' Offices/Clinics
      • Research Institutes

      By Disease Type

      • Gastroenteritis
      • Meningoencephalitis
      • Other Diseases
      • Sepsis

      REST OF EUROPE: POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2023–2030

      Segment20232024202520262027202820292030CAGR (%)
      HOSPITALS133.3145.4159.8177.5199.2225.9258.2298.413.3
      OTHER END USERS39.742.245.148.753.258.865.473.510.3
      PHYSICIANS' OFFICES/CLINICS104.9113.1122.8134.6149.2166.9188.2214.411.8
      RESEARCH INSTITUTES1414.615.416.417.619.120.923.18.5
      TOTAL292315.3343.2377.2419.3470.7532.7609.412.2

      EUROPE: POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2023–2030

      Segment20232024202520262027202820292030CAGR (%)
      HOSPITALS548.3591.5643706783.9879.1993.81135.612
      OTHER END USERS162.9170.8180.4192.5207.8226.5248.9276.48.9
      PHYSICIANS' OFFICES/CLINICS447.9479.1516.1561.5617.4685.4766.9866.910.9
      RESEARCH INSTITUTES53.955.7586164.869.675.382.47.3
      TOTAL12131297.11397.515211673.91860.62084.92361.411.1

      Target Audience

      • Diagnostics Manufacturers : In vitro diagnostics and molecular testing companies need Europe-specific market data to guide product launches, identify high-growth markets, and develop region-tailored commercialization strategies.
      • Healthcare Providers & Hospital Networks : European hospitals and clinical laboratories require market insights to evaluate POC molecular diagnostic adoption, benchmark against peers, and optimize diagnostic service offerings.
      • Investment & Private Equity Firms : Investors targeting the European diagnostics sector need detailed market sizing, growth forecasts, and country-level analysis to identify acquisition targets and assess portfolio company performance.
      • Healthcare Consultants & Advisors : Management consulting firms and healthcare advisors use regional market data to support client strategy development, competitive analysis, and market entry planning across European markets.
      • Regulatory & Policy Bodies : European health authorities and policy organizations leverage market intelligence to inform healthcare policy, reimbursement strategies, and diagnostic technology adoption frameworks.

      Europe vs. other regions

      HowEurope compares to the other 3 regional blocs covered in this market.

      North America
      ~USD 1985.7 Million · 10.6% wtd CAGR ·
      Asia Pacific
      ~USD 815.1 Million · 13.1% wtd CAGR ·
      Latin America
      ~USD 171.7 Million · 9.7% wtd CAGR ·
      Middle East & Africa
      ~USD 102 Million · 8.5% wtd CAGR ·

      Countries within Europe - compare and drill down

      Country2025 size (native)
      GermanyUSD 559 Million
      UKUSD 468 Million
      FranceUSD 209.8 Million
      ItalyUSD 157.6 Million
      SpainUSD 111.4 Million
      Rest Of EuropeUSD 388.6 Million

      Country market size visualization

      Germany
      USD 559 Million
      UK
      USD 468 Million
      France
      USD 209.8 Million
      Italy
      USD 157.6 Million
      Spain
      USD 111.4 Million
      Rest Of Europe
      USD 388.6 Million

      Reasons to Buy this Report

      • Regional Market Segmentation : Gain detailed insights into Europe's five largest markets (Germany, UK, France, Italy, Spain) plus Rest of Europe, enabling targeted market entry and expansion strategies specific to regional healthcare dynamics.
      • Competitive Benchmarking : Understand Europe's 12% CAGR advantage over the global 10.5% average, identifying growth drivers and competitive opportunities that differentiate the European market from other regions.
      • Regulatory & Infrastructure Insights : Access analysis of Europe's advanced healthcare infrastructure, regulatory frameworks, and adoption patterns that influence market dynamics and inform product development and commercialization strategies.
      • Five-Year Forecast Data : Leverage comprehensive projections showing market expansion from $870.7M to $1,531.3M by 2030, supporting strategic planning, investment decisions, and revenue forecasting for European operations.
      • Country-Level Market Intelligence : Utilize granular market size data for individual European countries to prioritize market entry, allocate resources efficiently, and develop localized go-to-market strategies aligned with regional demand.

      Frequently asked questions

      What is the current market size of point-of-care molecular diagnostics in Europe?

      Europe's point-of-care molecular diagnostics market is valued at $870.7 million in 2025, with strong growth anticipated through the forecast period.

      What is the projected market size for Europe by 2030?

      Europe's market is forecast to reach $1,531.3 million by 2030, representing a 12.0% compound annual growth rate from 2025 to 2030.

      How does Europe's growth rate compare to the global market?

      Europe's 12.0% CAGR significantly exceeds the global average of 10.5%, positioning Europe as a high-growth region for point-of-care molecular diagnostics.

      What factors are driving growth in Europe's point-of-care molecular diagnostics market?

      Key drivers include advanced healthcare infrastructure, aging populations, pandemic preparedness initiatives, regulatory support, and increasing integration of rapid diagnostics into primary care and emergency departments.

      Which European regions are expected to show the strongest growth?

      Both Western and Eastern European markets are expected to experience significant growth, supported by technological advancements, strategic partnerships, and regulatory approvals through 2030.

      RESEARCH METHODOLOGY

      The study involved estimating activities to determine the current size of the point-of-care molecular diagnostics market. Exhaustive secondary research was done to collect information on the point-of-care molecular diagnostics industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the point-of-care molecular diagnostics market.

      Secondary Research

      In the secondary research process, various secondary sources, such as annual reports, press releases, and investor presentations of companies; white papers; certified publications; articles by recognized authors; gold-standard & silver-standard websites; regulatory bodies; and databases like D&B Hoovers, Bloomberg Business, and Factiva, were referred to identify and collect information for this study.

      Primary Research

      In the primary research process, primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts, C-level executives, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess prospects.

      Breakdown of Primaries

      Point-of-Care Molecular Diagnostics Market

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      Both bottom-up and top-down approaches were used to estimate and validate the point-of-care molecular diagnostics market’s total size. These methods were also used extensively to estimate the size of various subsegments in tkehe mart. The research methodology used to estimate the market size includes the following:

      • The key players in the industry have been identified through extensive secondary research.
      • The revenues generated by leading players operating in the point-of-care molecular diagnostics market have been determined through primary and secondary research.
      • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
      Point-of-Care Molecular Diagnostics Market

      Data Triangulation

      After arriving at the overall market size by applying the abovementioned process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

      Market Definition

      Point-of-care molecular diagnostics includes various portable point-of-care devices and assays used by healthcare professionals to detect and diagnose diseases in humans using different techniques to identify and analyze nucleic acids or proteins at the molecular level.

      Stakeholders

      • Manufacturers and distributors of point-of-care molecular diagnostics products
      • Physicians’ offices
      • Hospitals and clinics
      • Research institutes
      • Point-of-care molecular diagnostics service providers
      • Government associations
      • Venture capitalists and investors

      Report Objectives

      • To define, describe, segment, and forecast the point-of-care molecular diagnostics market by product & service, technology, sample type, application, end user, and region
      • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
      • To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall market
      • To analyze opportunities for stakeholders and provide details of the competitive landscape for key players
      • To forecast the size of the market segments with respect to five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
      • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
      • To track and analyze company developments such as acquisitions, expansions, product launches & approvals, and other developments in the point-of-care molecular diagnostics market
      • To benchmark players within the point-of-care molecular diagnostics market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings
      • To study the impact of AI/Gen AI on the market, along with the macroeconomic outlook for each region

       

      Get the Full Point-of-Care Molecular Diagnostics Market Report

      Full forecast, segment splits, and company analysis for all Point-of-Care Molecular Diagnostics Market.

      Download Sample Pages Buy Report

      METHODOLOGY

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      Cite this Research
      DMCA.com Protection Status